Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Bright Minds Biosciences Inc
DRUGCurrent price
1.47 CAD
0 CAD (0.00%)
Last closed
1.29 USD
Company
brightmindsbio.com
ISIN
CA10919W1086
Sector
Healthcare
Industry
Biotechnology
Exchange
Canadian Securities Exchange
Capitalization
5 691 396 USD
Yield for 12 month
-27.33 %
1Y
3Y
5Y
10Y
15Y
DRUG
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also developing BMB-202 for the treatment of depression, anxiety, and PTSD; and BMB-201 for the treatment of anxiety. It has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. Bright Minds Biosciences Inc. was founded in 2017 and is headquartered in New York, New York. Address: 19 Vestry Street, New York, NY, United States, 10013
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
4.87 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-53 322 USD
Last Year
-4 443 USD
Current Quarter
-13 331 USD
Last Quarter
-13 330 USD
Key Figures DRUG
1 year
3 years
5 years
10 years
EBITDA
–
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-28.86 %
PEG Ratio
–
Return On Equity TTM
-51.8 %
Wall Street Target Price
4.87 USD
Revenue TTM
–
Book Value
1.37 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.65 USD
Diluted Eps TTM
-0.65 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics DRUG
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History DRUG
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:5
Payout Ratio
–
Last Split Date
14.07.2023
Dividend Date
–
Stock Valuation DRUG
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.0716
Price Book MRQ
1.2671
Financials DRUG
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators DRUG
For 52 weeks
0.93 USD
2.39 USD
50 Day MA
1.11 USD
Shares Short Prior Month
72 692
200 Day MA
1.35 USD
Short Ratio
0.82
Shares Short
181 456
Short Percent
5.07 %
BeatStart